SCHEMBL5775409

SCHEMBL5775409

Fc1ccc(N2CCN(CCc3[nH]nc4c3CCCC4)CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.45
DRD2 P14416 4/20 0.45
HTR2A P28223 3/20 0.45
DRD3 P35462 2/20 0.45
TMEM97 Q5BJF2 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
DRD1 P21728 1/20 0.45
DRD5 P21918 1/20 0.45
HTR2C P28335 1/20 0.45
HRH1 P35367 1/20 0.45
ADRA1D P25100 3/20 0.44
ADRA1A P35348 3/20 0.44
ADRA1B P35368 3/20 0.44
MAPT P10636 1/20 0.42
SLC27A1 Q6PCB7 3/20 0.41
DRD4 P21917 1/20 0.41
SLC6A4 P31645 1/20 0.41
GAA P10253 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774541 0.93 HTR1A (0.49) HTR1ADRD2HTR2ADRD3TMEM97
SCHEMBL5774579 0.92 HTR1A (0.54) HTR1ADRD2HTR2ADRD3TMEM97
SCHEMBL7960754 0.92 HTR1A (0.48) HTR1ADRD2HTR2ADRD3TMEM97
Hydrochloric Acid SCHEMBL5772589 0.92 HTR1A (0.48) HTR1ADRD2HTR2ADRD3TMEM97
Hydrochloric Acid SCHEMBL5775839 0.89 HTR1A (0.45) HTR1ADRD2HTR2ADRD3TMEM97
Fumaric Acid SCHEMBL5799811 0.84 DRD4 (0.47) HTR1ADRD2HTR2ADRD3TMEM97
Maleic Acid SCHEMBL5799806 0.84 DRD4 (0.47) HTR1ADRD2HTR2ADRD3TMEM97
SCHEMBL5775439 0.83 MAPT (0.45) DRD2DRD3SIGMAR1HRH1ADRA1D
SCHEMBL5775029 0.82 MAPT (0.44) DRD2DRD3SIGMAR1HRH1ADRA1D
SCHEMBL7964122 0.81 MAPT (0.45) DRD2DRD3SIGMAR1MAPTSLC27A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed